“The first batch of Internet medical care has been first settled by safe doctors.”
Editor’s note: This article is from WeChat public account “Financial Graffiti” (ID: caijingtuya), author Stone Jin, editor tuya; authorized to publish.
According to the company’s intelligence expert “Financial Graffiti” news, the comprehensive medical service organization Micromedicine Group carried out a new round of equity pledge on August 26, the number of pledged shares was 41.2 million shares, which is already micro-medicine 2019 The third attempt for equity pledge.
Industrial and commercial information shows that the micro-medical company Micromedical Group (Zhejiang) Co., Ltd. first carried out equity pledge on March 27, and the pledge institution was Hangzhou Xiaoshan Sub-branch of Shanghai Pudong Development Bank Co., Ltd., at which time the number of pledged shares was 2060 shares, accounting for 9.58% of the total share capital.
On April 29, the micro-medical again tried to pledge 41.2 million shares, but details of the latest two pledges have not been announced.
Public information shows that the micro-medicine was founded in 2010 by Liao Jieyuan and his team, formerly known as the registered network; as of May 2018, the micro-medical coverage of more than 2,700 key hospitals and 240,000 doctors in 30 provinces and cities nationwide The number of registered users of real names exceeds 160 million, and the cumulative number of serviced users exceeds 580 million.
As one of the largest medical health technology companies in China, Micromedicine has completed 8 rounds of financing so far, including Tencent, Gaochun Capital, Sequoia Capital, Morningside Capital, Qiming Venture Capital, and Fosun Ruizheng. Capital and other first-line VC. Among them, On May 9, 2018, the micro-medical announced the completion of the $500 million pre-IPO strategic financing, and AIA and NWS Holdings led the investment, with a post-mortem valuation of $5.5 billion. In this round of financing, the micro-medicine only transferred a single-digit share ratio, and the chairman and CEO of the micro-medicine, Liao Jieyuan, remained the largest shareholder.
It is worth noting that one month before the official delivery of the pre-IPO round of financing, Chief Strategy Officer of MicromedicineChen Hongzhe said in an interview with China Business News that “If there is no mistake, the micro-medicine will go to Hong Kong at the end of 2018“; at the same time, he also said that the micro-medical IPO is a spin-off. At the time of listing, there were four business segments of Micro Medical Cloud, Micro Medical, Micromedicine and Micro Medical Insurance.
According to the plan of micro-medicine, Weijiyun will be listed on the A-share market. One of the reasons given is that the micro-medicine cloud stores a large amount of medical information of the mainland China population; the remaining HMO (health management organization) Will consider listing in Hong Kong stocks.
In February of this year, Bloomberg also reported that the micro-medicine is undergoing a large-scale restructuring and is considering splitting part of its business into the Kechuang Board, which is most likely a cloud business.
In spite of failing to fulfill the plan to complete the listing in 2018, micro-medicine frequently shot in the A-share market in the first half of 2019.
In January, Yi Lianzhong (300096) announced that micro-medicine purchased 21.5 million shares of the company, accounting for 5% of the total issued shares; then the micro-medicals increased their holdings by 1.44%, 1%, 1%, 1.14 respectively. % of the shares, holding a total of 9.5814% of the shares of Yilian, micromedical chairman Liao Jieyuan and micro-medicine product director Kong Xiangpu as a non-independent director.
In May, Hangfang Advance (601177) issued a notice stating that 45.01% of Xiaoshan State-owned shares transferred 19.99% of the shares (79.972 million shares) of Hangzhou Tooth in the form of public collection of transferees, which was approved by Zhejiang Provincial State-owned Assets Supervision and Administration Commission. Hangzhou Guangfa Technology, the founder and CEO of Micromedical Group, Liao Jieyuan, successfully entered the market and became the second largest shareholder.
On May 4, 2018, Ping An’s doctors took the lead and became the first Internet medical company in China. It is only the current share price of HK$45.65, which is more than 15% lower than the issue price of HK$54.8.
Therefore, for the micro-medicine who claimed to have been fully profitable as early as 2016, the profitability of each business segment will be selected in A, H or Kechuang, respectively, and will be decided in the follow-up decision. The key to its market performance.
This article was originally written by the public finance graffiti (ID: caijingtuya). If you need to reprint, please contact Graffiti.